The UArizona Cancer Center conducts novel research focused on developing new and better approaches to preventing, diagnosing and treating cancer. The center is the only one in Arizona with the highest designation awarded by the National Cancer Institute.Continue reading
Category Archives: AZBio News
ASU awarded lead of new National Science Foundation I-Corps Hub
Expansion of National Innovation Network to accelerate translation of research ideas to the marketplaceContinue reading
C-Path’s Kristen Swingle Named President
Swingle joined C-Path in 2019 and was named interim president in 2021
TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-Path) today announced that its Chief Operating Officer (COO) and Interim President, Kristen Swingle, M.S., has been named COO and President, effective immediately. Swingle has filled the interim President role since 2021, stewarding C-Path through growth and innovation, including the establishment of multiple national and global programs, a new European entity, a 50% staff increase, and a 90% increase in revenue.Continue reading
Study: Newly discovered predator damaging our ecosystems
ASU researchers discover new predatory bacteria in soil biocrustsContinue reading
Rachna Nath is Developing Future Innovators
Rachna Nath is developing future innovators as a teacher at the Arizona College Prep High School within Chandler Public School District. She is being honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on September, 28, 2022. Continue reading
The 2023 Flinn Bioscience Entrepreneurship Program
The Flinn Foundation Bioscience Entrepreneurship Program offers funding, professional support, connections, and networking opportunities to Arizona early-stage bioscience firms.Continue reading
App Created by MD/PhD Student Provides Accessible Training Resource for Adaptive Sports
“I did some research and saw there were almost zero apps specifically designed for people who use wheelchairs,” Conner said.Continue reading
C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Lysosomal Diseases
TUCSON, Ariz., Sept. 1, 2022 — Critical Path Institute (C-Path) today announced the launch of a pre-consortium collaboration focused on accelerating medical product development in lysosomal diseases, supported by a grant from the U.S. Food and Drug Administration (FDA).Continue reading
Meet Arizona Bioscience Pioneer Dr. Michael Lynch
Michael Lynch honored with the 2022 Arizona Bioscience Pioneer Award for Lifetime Achievement Continue reading
Upcoming Rare Disease Workshop Focuses on the Importance of Data Sharing in Drug Development
C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platform on rare disease drug developmentContinue reading